Condensed Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 25,000	$ 25,000
Prepaid expenses	485,388
Total current assets	510,388	25,000
Deferred offering costs associated with proposed initial public offering		131,695
Other assets	150,212
Cash equivalents held in Trust Account	250,014,385
Total Assets	250,674,985	156,695
Current Liabilities:
Accrued expenses	2,189,604	94,560
Payables to related party		37,640
Sponsor loan - promissory notes	1,197,223
Franchise tax payable	145,455
Total Current Liabilities	3,532,282	132,200
Warrant liability	8,277,333
Forward purchase securities liability	2,055,630
Total Liabilities	13,865,245	132,200
Commitments and Contingencies
Class A common stock subject to possible redemption, 25,000,000 and 0 shares at redemption value of $10.00 per share as of September 30, 2021 and December 31, 2020, respectively	250,000,000
Stockholders’ Equity (Deficit):
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of both September 30, 2021 and December 31, 2020
Class A common stock, $0.0001 par value; 240,000,000 shares authorized; 600,000 issued and outstanding (excluding 25,000,000 shares subject to possible redemption) as of September 30, 2021 and no shares issued and outstanding as of December 31, 2020	60
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 6,250,000 and 7,187,500 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively	625	719
Additional paid-in capital		24,281
Accumulated deficit	(13,190,945)	(505)
Total Stockholders’ Equity (Deficit)	(13,190,260)	24,495
Total Liabilities and Stockholders’ Equity (Deficit)	$ 250,674,985	$ 156,695